During the past decade, Saint Joseph Regional Medical Center-Mishawaka conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 155 clinical trials were completed, i.e. on average, 3875% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 45 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Regional Medical Center-Mishawaka" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 76 trials, followed by "National Cancer Institute (NCI)" with 65 trials sponsored, "Gynecologic Oncology Group" with 26 trials sponsored, "Eastern Cooperative Oncology Group" with 17 trials sponsored and "SWOG Cancer Research Network" with 17 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Regional Medical Center-Mishawaka" #1 collaborator was "National Cancer Institute (NCI)" with 163 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Regional Medical Center-Mishawaka" are "Breast Cancer" (39 trials), "Lung Cancer" (18 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (16 trials), "Colorectal Cancer" (12 trials) and "Lymphoma" (11 trials). Many other conditions were trialed in "Saint Joseph Regional Medical Center-Mishawaka" in a lesser frequency.

Most popular intervention types in "Saint Joseph Regional Medical Center-Mishawaka" are "Drug" (188 trials), "Other" (119 trials), "Biological" (71 trials), "Procedure" (36 trials) and "Radiation" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Quality-of-Life Assessment" (36 trials), "placebo" (33 trials), "Paclitaxel" (29 trials) and "Carboplatin" (24 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Regional Medical Center-Mishawaka" are 141 trials for "All" genders, 81 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Regional Medical Center-Mishawaka". undefined are not yet recruiting, 1 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 147 completed trials in Saint Joseph Regional Medical Center-Mishawaka, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Regional Medical Center-Mishawaka, 7 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 121 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Saint Joseph Regional Medical Center-Mishawaka has several departments that took part in Clinical trials: "St. Joseph's Radiation Oncology Center" - 11 trials